Meet the Professor
We are on the right road | A brief history of breast cancer guidelines in China
Translational Breast Cancer Research
2021;
2:
26
(31 July 2021)
Editorial Commentary
Neoadjuvant chemotherapy choices from population selection to regimen design: the St. Gallen International Expert Consensus Conference 2021
Translational Breast Cancer Research
2021;
2:
25
(31 July 2021)
Editorial Commentary
Updated interpretation for early breast cancer in The Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines
Translational Breast Cancer Research
2021;
2:
24
(31 July 2021)
Original Article
Development and validation of a nomogram for predicting the status of estrogen receptor-low-positive breast cancer
Translational Breast Cancer Research
2021;
2:
23
(31 July 2021)
Review Article
2021 updates in postoperative radiotherapy section of Chinese Society of Clinical Oncology Breast Cancer guideline
Translational Breast Cancer Research
2021;
2:
22
(31 July 2021)
Review Article
St. Gallen 2021 Chinese expert perspective of optimal regional management
Translational Breast Cancer Research
2021;
2:
21
(31 July 2021)
Review Article
A review of endocrine therapy in early estrogen receptor-positive breast cancer by St. Gallen Breast Cancer Conference 2021
Translational Breast Cancer Research
2021;
2:
20
(31 July 2021)
Review Article
Optimizing HER2-positive breast cancer therapy through neoadjuvant platforms: controversies and concepts
Translational Breast Cancer Research
2021;
2:
19
(31 July 2021)
Review Article
Introduction to the key contents of the Chinese Society of Breast Surgery Practice Guideline 2021
Translational Breast Cancer Research
2021;
2:
18
(31 July 2021)
Review Article
Expert review on systemic treatment in the St. Gallen International Breast Cancer Conference 2021
Translational Breast Cancer Research
2021;
2:
17
(31 July 2021)
